Home
/
RenovoRx, Inc.
/
Financials
/
Quarterly
RenovoRx, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that RenovoRx, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$266.0K
Nov 13, 2025
Q2
2025
Jun 30, 2025
$422.0K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$197.0K
May 15, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.91M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($2.90M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($2.90M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($2.42M)
May 15, 2025
Q2
2025
Mar 31, 2025
($2.42M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($2.42M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($2.47M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($2.39M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($2.39M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.08M)
May 15, 2025
Q2
2025
Mar 31, 2024
($1.08M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($1.08M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($1.42M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($2.33M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.33M)
Aug 13, 2024
Q2
2024
Mar 31, 2023
($3.26M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($3.26M)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($3.26M)
May 10, 2024
Q3
2023
Sep 30, 2022
($2.14M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($2.59M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.20M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($2.68M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.11M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.83M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($3.03M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.48M)
May 15, 2025
Q3
2024
Sep 30, 2023
($2.98M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.38M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($3.26M)
May 10, 2024
Q3
2023
Sep 30, 2022
($2.16M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($2.61M)
Aug 16, 2023
Q1
2023
Mar 31, 2022
($3.01M)
May 12, 2023
Q3
2022
Sep 30, 2021
($1.40M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($866.0K)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($1.05M)
May 13, 2022
Q3
2021
Sep 30, 2020
($910.0K)
Nov 15, 2021